Dark

Check out our Dark Pool Levels

CHAQ
Chardan Healthcare Acquisition 2 Corp.
stock NYSE

Inactive

Sep 3, 2021 9:31:00 AM EDT

0.00USD-100.000%(-8.41)242,664

Pre-market

0.00USD-100.000%(-9.36)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Sep 1, 2021

04:44PM EDT Chardan Healthcare Acquisition 2 Announces Stockholder Approval Of Business Combination With Renovacor Benzinga

04:43PM EDT Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of PR Newswire

Aug 25, 2021

03:15PM EDT Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of PR Newswire

Aug 3, 2021

04:06PM EDT Chardan Healthcare Acquisition 2 Corp. Announces Record Date for Stockholders PR Newswire

Jul 19, 2021

07:00AM EDT Renovacor, Inc. (Renovacor), an earlystage biotechnology company developing adeno-associated virus (AAV)based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Elizabeth (Beth) White, Ph.D., as chief business officer and senior vice president of operations. GlobeNewswire Inc

Jul 12, 2021

07:01AM EDT Renovacor, Inc. (Renovacor), an earlystage biotechnology company developing adeno-associated virus (AAV)based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Jiwen Zhang, Ph.D., as senior vice president, regulatory affairs and quality assurance. GlobeNewswire Inc

Jun 29, 2021

07:00AM EDT Renovacor Announces the Appointments of Joan Lau, Ph.D., and GlobeNewswire Inc

Jun 2, 2021

07:00AM EDT Renovacor Announces the Appointment of Marc Semigran, M.D., as GlobeNewswire Inc

Mar 23, 2021

08:10AM EDT Renovacor To Merge With Chardan Healthcare Acquisition 2 Corp. Benzinga

08:03AM EDT Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp. PR Newswire

Share